Divine Aleru, Microbiome Signatures Research Coordinator

Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.

Enterococcus faecalis is a gut‑adapted, Gram‑positive, non‑spore‑forming facultative anaerobe that becomes an important opportunistic pathogen in healthcare when host barriers are breached or antibiotics select for enterococcal overgrowth. Its clinical impact is driven more by persistence, adhesion, and biofilm biology, quorum‑regulated secreted effectors (fsr‑controlled gelatinase GelE), and high genome plasticity than by a broad repertoire of classical tissue‑destroying toxins. Antimicrobial decision‑making must account for the intrinsic poor activity of cephalosporins, the potential for transferable glycopeptide resistance mediated by van gene clusters, and the need for regimen selection in endocarditis that respects synergy/tolerance and local high‑level aminoglycoside resistance patterns.

Enterococcus faecium (VREfm) has become a major healthcare threat due to its ability to acquire resistance and adapt to both clinical and environmental conditions. This review calls for new strategies to combat VREfm, emphasizing its transmission through multiple routes and the need for better diagnostic and treatment approaches.

Enterococcus faecalis utilizes five distinct iron uptake systems, including novel transporters, to maintain iron homeostasis and support virulence. Heme acquisition also plays a critical role in its pathogenesis. Targeting these transporters offers a promising approach for treating E. faecalis infections.

What was studied? This study examined the role of manganese (Mn) acquisition in the virulence of Enterococcus faecalis. Researchers identified and characterized the key manganese transport systems in E. faecalis, focusing on the ABC-type transporter EfaCBA and two Nramp-type transporters, MntH1 and MntH2. They tested how these transport systems contribute to bacterial growth in manganese-limited […]

What was studied? This study examined the Fsr quorum-sensing system in Enterococcus faecalis and its role in regulating the surface display of the collagen-binding protein Ace, a key virulence factor. Researchers investigated how disruption of the Fsr system, as well as GelE protease activity, influenced the expression of Ace on the cell surface, its ability […]

Enterococcus faecium adapts through gene transfer and resistance mechanisms, making it a major cause of hospital infections. The study emphasizes the importance of genomic surveillance and the development of novel therapeutics like phage therapy and microbiota-based treatments to control the spread of VREfm infections.

VanB Enterococcus strains show inducible vancomycin resistance, enabling microbiome persistence and infection risk. Diagnostic methods reliably detect resistant strains, but low-level resistance may be missed. Enterococcus resistance expansion represents a key microbiome signature associated with hospital infection and treatment failure.

What was reviewed? This review examined how Enterococcus faecalis and Enterococcus faecium regulate VanA- and VanB-type glycopeptide resistance, which enables survival during vancomycin and related antibiotic exposure. The authors reviewed molecular, genetic, and microbiological evidence explaining how resistance genes alter peptidoglycan synthesis and how regulatory systems activate resistance in response to antibiotic exposure. The review […]

What was reviewed? This review examined how Enterococcus faecalis and Enterococcus faecium adapt to the gut microbiome, hospital environments, and host tissues through genetic plasticity, antimicrobial resistance, and virulence factor acquisition. The authors reviewed microbiological, genomic, and clinical evidence explaining how Enterococcus survives environmental stress, acquires resistance genes, and transitions from a gut microbiome commensal […]

Enterococcus develops antibiotic resistance through genetic adaptation, enabling microbiome dominance and infection persistence. Resistance mechanisms allow Enterococcus to survive antibiotic exposure, expand in the gut microbiome, and spread resistance genes, making Enterococcus expansion a key microbiome signature linked to infection risk and antimicrobial resistance.

Enterococcus faecalis uses pheromone signaling to detect microbiome conditions, transfer antibiotic resistance genes, and activate virulence. This system promotes microbiome persistence, bacterial aggregation, and infection risk, making pheromone signaling an important microbiome signature of Enterococcus pathogenicity.

Enterococcus faecalis pili and adhesins enable microbiome persistence, collagen adherence, biofilm formation, and urinary tract infection. Loss of these factors reduces microbiome colonization and infection severity, identifying pili and adhesins as key microbiome virulence signatures linked to infection risk.

This review shows that Enterococcus expands during microbiome disruption, forms polymicrobial biofilms, and activates virulence factors that promote colonization, immune evasion, and systemic infection, identifying Enterococcus as a microbiome-driven pathobiont linked to increased infection risk and poor clinical outcomes.

Cytolysin allows Enterococcus faecalis to disrupt the microbiome, kill competitors, evade immune defenses, and increase infection severity. This toxin promotes microbial imbalance, pathogen expansion, and systemic infection, making cytolysin a key microbiome virulence factor and clinical biomarker.

Enterococcus faecalis regulates immune tolerance and microbiome stability but becomes pathogenic during dysbiosis. It increases IgA production, modulates inflammatory signaling, and strengthens gut barrier function in eubiosis. In dysbiosis, it expands, evades immune clearance, promotes inflammation, and contributes to systemic infections, making it a key microbiome biomarker of immune and microbial imbalance.

Clostridium perfringens is a fast-growing, Gram-positive, spore-forming anaerobe and a major toxin-mediated pathogen affecting humans and animals. Widely distributed in soil, food, and gastrointestinal microbiota, it causes diseases ranging from food poisoning and antibiotic-associated diarrhoea to life-threatening clostridial myonecrosis. Its pathogenicity is driven by diverse plasmid-encoded toxins, including α-toxin, enterotoxin, and perfringolysin O, while conjugative mobile genetic elements facilitate rapid dissemination of antimicrobial resistance and virulence traits. Genome-informed toxinotyping and molecular surveillance are therefore essential for accurate risk assessment, clinical management, and outbreak control.

This study showed that vaccination against Clostridium perfringens type C protects piglets by generating neutralizing antibodies against beta toxin, preventing microbiome-driven intestinal necrosis and infection risk. Passive immunity depends on sufficient maternal antibody production and transfer through colostrum, which can be improved through optimized vaccination protocols.

This review expands the Clostridium perfringens toxinotyping scheme to include toxinotypes F and G, linking enterotoxin and NetB production to specific microbiome-driven diseases. It highlights plasmid-mediated toxin transfer, improved microbial classification, and enhanced diagnostic precision for microbiome-associated enteric and systemic infections.

What was reviewed? This review examined the biological mechanisms, clinical applications, and translational potential of hyperbaric oxygen therapy (HBOT), a treatment that delivers 100% oxygen under elevated atmospheric pressure to increase oxygen availability in tissues. The authors analyzed how HBOT improves oxygen diffusion, enhances angiogenesis, regulates immune responses, and exerts antimicrobial effects, and they evaluated […]

This review showed that toxin-producing Clostridium perfringens drives necrotizing infections by disrupting microbiome balance, destroying tissue, and promoting rapid pathogen expansion and disease progression.

This review showed that toxin plasmids control virulence in Clostridium perfringens by enabling toxin gene transfer between microbiome strains, allowing commensal bacteria to become pathogenic and increasing infection risk.

This study showed that Clostridium perfringens spore germination depends on specific germinant receptors, especially GerK, which detect nutrients like potassium and amino acids. GerK controls dipicolinic acid release, metabolic activation, and colony formation, establishing a direct link between environmental nutrient sensing and pathogen activation within the microbiome.

This review explains how the VirS/VirR regulatory system controls toxin production and virulence in Clostridium perfringens. Microbiome signals activate toxin genes, enabling the bacterium to transition from commensal colonizer to pathogenic organism and cause tissue damage, infection, and disease.